What is Marijuana Inc.?
, a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Marijuana, Inc. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.80M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.